Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elion

Showing results (401-410 of 518) with videos related to

Pageof 52
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000
Schedule-dependent activity of temozolomide plus CPT-11 against a human central nervous system tumor-derived xenograftV J Patel, G B Elion, P J Houghton, et al.
Cancer Research|December 15, 1989
Establishment of a melphalan-resistant rhabdomyosarcoma xenograft with cross-resistance to vincristine and enhanced sensitivity following buthionine sulfoximine-mediated glutathione depletionM C Rosenberg, O M Colvin, O W Griffith, et al.
Archives of Neurology|September 12, 2007
Efficacy and safety of tadalafil in men with erectile dysfunction following spinal cord injuryFrançois Giuliano, Antonio Sanchez-Ramos, Dieter Löchner-Ernst, et al.
Plos One|February 8, 2011
Genetic variation among major human geographic groups supports a peculiar evolutionary trend in PAX9Vanessa R Paixão-Côrtes, Diogo Meyer, Tiago V Pereira, et al.
Cancer Research|August 11, 1991
Therapeutic analysis of melphalan-resistant human rhabdomyosarcoma xenograft TE-671 MRE R Lilley, G B Elion, M W Dewhirst, et al.
Journal of the American Society of Nephrology : JASN|August 18, 2017
A Heterologous Model of Thrombospondin Type 1 Domain-Containing 7A-Associated Membranous NephropathyNicola M Tomas, Catherine Meyer-Schwesinger, Hanning von Spiegel, et al.
IJID Regions|April 20, 2026
Anti-tuberculosis drug-induced hepatotoxicity among patients undergoing tuberculosis treatment at the Antituberculosis Center of Brazzaville, Republic of CongoEmmanuel Fonfon Ebata-Mboussa, Darrel Ornelle Elion Assiana, Nanikany Moyen, et al.
Radiation Research|February 1, 1992
Hyperthermia-induced enhancement of melphalan activity against a melphalan-resistant human rhabdomyosarcoma xenograftD T Laskowitz, G B Elion, M W Dewhirst, et al.
AIDS (London, England)|March 7, 2025
Outcomes in people with HIV who resume or switch to bictegravir/emtricitabine/tenofovir alafenamide following a treatment interruptionGraeme Moyle, Joshua Gruber, Megan Dunbar, et al.
Cancer Research|August 1, 1988
Experimental chemotherapy of human medulloblastoma cell lines and transplantable xenografts with bifunctional alkylating agentsH S Friedman, O M Colvin, S X Skapek, et al.
Pageof 52

Showing results (401-410 of 518) with videos related to

Sort By:
Pageof 52
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000
Schedule-dependent activity of temozolomide plus CPT-11 against a human central nervous system tumor-derived xenograftV J Patel, G B Elion, P J Houghton, et al.
Cancer Research|December 15, 1989
Establishment of a melphalan-resistant rhabdomyosarcoma xenograft with cross-resistance to vincristine and enhanced sensitivity following buthionine sulfoximine-mediated glutathione depletionM C Rosenberg, O M Colvin, O W Griffith, et al.
Archives of Neurology|September 12, 2007
Efficacy and safety of tadalafil in men with erectile dysfunction following spinal cord injuryFrançois Giuliano, Antonio Sanchez-Ramos, Dieter Löchner-Ernst, et al.
Plos One|February 8, 2011
Genetic variation among major human geographic groups supports a peculiar evolutionary trend in PAX9Vanessa R Paixão-Côrtes, Diogo Meyer, Tiago V Pereira, et al.
Cancer Research|August 11, 1991
Therapeutic analysis of melphalan-resistant human rhabdomyosarcoma xenograft TE-671 MRE R Lilley, G B Elion, M W Dewhirst, et al.
Journal of the American Society of Nephrology : JASN|August 18, 2017
A Heterologous Model of Thrombospondin Type 1 Domain-Containing 7A-Associated Membranous NephropathyNicola M Tomas, Catherine Meyer-Schwesinger, Hanning von Spiegel, et al.
IJID Regions|April 20, 2026
Anti-tuberculosis drug-induced hepatotoxicity among patients undergoing tuberculosis treatment at the Antituberculosis Center of Brazzaville, Republic of CongoEmmanuel Fonfon Ebata-Mboussa, Darrel Ornelle Elion Assiana, Nanikany Moyen, et al.
Radiation Research|February 1, 1992
Hyperthermia-induced enhancement of melphalan activity against a melphalan-resistant human rhabdomyosarcoma xenograftD T Laskowitz, G B Elion, M W Dewhirst, et al.
AIDS (London, England)|March 7, 2025
Outcomes in people with HIV who resume or switch to bictegravir/emtricitabine/tenofovir alafenamide following a treatment interruptionGraeme Moyle, Joshua Gruber, Megan Dunbar, et al.
Cancer Research|August 1, 1988
Experimental chemotherapy of human medulloblastoma cell lines and transplantable xenografts with bifunctional alkylating agentsH S Friedman, O M Colvin, S X Skapek, et al.
Pageof 52